drugset / Trial / NCT03971383
Phase Ⅱc Sutdy of Aolanti Weikang Tablets in FD PDS Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and validity of Aolanti Weipang Tablets in Patients with Postprandial Discomfort Syndrome of Functional Dyspepsia
Timeline
- Start
- 2019-06-10
- Primary completion
- 2020-10-31
- Completion
- 2021-05-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aolanti Weipang Tablets | Unknown | — | Oral |